Skip to content

PP&E (Net) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$7.66B+6.2%
Gilead Sciences logo
Gilead SciencesGILD
$5.64B+4.0%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$112.18M-13.3%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$342K-43.7%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$15.52M-38.2%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$131.39M+17.8%

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$907.23M+54.1%
Enterprise value$898.76M+53.9%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sana Biotechnology's PP&E (net)?
Sana Biotechnology (SANA) reported PP&E (net) of $25.67M in Q1 2026.
How has Sana Biotechnology's PP&E (net) changed year-over-year?
Sana Biotechnology's PP&E (net) decreased by 65.2% year-over-year, from $73.69M to $25.67M.
What is the long-term trend for Sana Biotechnology's PP&E (net)?
Over 5 years (2020 to 2025), Sana Biotechnology's PP&E (net) has grown at a -10.5% compound annual growth rate (CAGR), from $46.78M to $26.91M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.